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Abstract Cranioplasty is a common neurosurgical proce-
dure. Free-hand molding of polymethyl methacrylate
(PMMA) cement into complex three-dimensional shapes is
often time-consuming and may result in disappointing cos-
metic outcomes. Computer-assisted patient-specific implants
address these disadvantages but are associated with long
production times and high costs. In this study, we evaluated
the clinical, radiological, and cosmetic outcomes of a time-
saving and inexpensive intraoperative method to mold
custom-made implants for immediate single-stage or delayed
cranioplasty. Data were collected from patients in whom
cranioplasty became necessary after removal of bone flaps
affected by intracranial infection, tumor invasion, or trauma.
A PMMA replica was cast between a negative form of the
patient’s own bone flap and the original bone flap with exactly
the same shape, thickness, and dimensions. Clinical and ra-
diological follow-up was performed 2 months post-surgery.
Patient satisfaction (Odom criteria) and cosmesis (visual ana-
logue scale for cosmesis) were evaluated 1 to 3 years after
cranioplasty. Twenty-seven patients underwent intraoperative
template-molded patient-specific cranioplasty with PMMA.
The indications for cranioplasty included bone flap infection
(56%, n015), calvarian tumor resection (37%, n010), and
defect after trauma (7%, n02). The mean duration of the
molding procedure was 19±7 min. Excellent radiological
implant alignment was achieved in 94% of the cases. All
(n023) but one patient rated the cosmetic outcome (mean
1.4 years after cranioplasty) as excellent (70%, n016) or good
(26%, n06). Intraoperative cast-molded reconstructive cranio-
plasty is a feasible, accurate, fast, and cost-efficient technique
that results in excellent cosmetic outcomes, even with large
and complex skull defects.
Keywords Patient-specific implant . Cranioplasty . Skull
bone flap . Bone replacement material polymethyl
methacrylate—PMMA . Brain tumors . Trauma . Brain
Introduction
Removal of the bone flap is a frequently performed neuro-
surgical procedure for malignant brain swelling, complex
skull fractures, intraosseous tumor invasion, primary or
secondary intracranial infections, and intraoperative con-
tamination [18, 37]. Reimplantation of the patient’s own
bone flap is the method of choice to restore brain protection
and cosmesis as well as to prevent intracranial low pressure
syndromes and maintain immunological compatibility [5,
31]. However, primary bone graft reimplantation is often
impossible in the case of extensive brain swelling, commi-
nuted fractures, skull bone infection, or tumor infiltration.
Additionally, difficulties in storage and timing of surgery
may lead to the loss of the bone flap.
Numerous synthetic materials, such as titanium [32],
polymethyl methacrylate (PMMA) [13, 28], carbon [41],
polyetheretherketone (PEEK) [2], hydroxyapatite (HA)
[42], ceramics [27], and osteoconductive bioresorbable
materials [8], have been applied to correct skull defects after
permanent removal of the bone flap. PMMA is the most
frequently used material to restore normal skull contour and
shape [28, 37]. It is stable, shows high biocompatibility, and
has biomechanical properties comparable to those of cranial
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bone [12]. Whereas smaller defects can be reconstructed
without difficulty, reconstruction of larger bone flaps, espe-
cially in the forehead and fronto-temporal region, poses a
problem [7]. In these cases, free-hand molding of PMMA
into complex three-dimensional shapes with correct and
uniform thickness is a time-consuming process that can
result in unsatisfactory cosmetic outcomes [11, 37].
These widely known problems led to the introduction of
image-based and computer-assisted manufactured (CAM)
implants [42]. Computer-assisted design (CAD) of bone
flaps has improved the cosmetic outcome and minimized
operation time for adjustment and insertion. However, these
techniques are associated with long production times and
high costs [42]. In order to avoid the high expenses of
CAM/CAD implants, various preoperative cast- and
template-based reconstruction methods have been imple-
mented to create similar patient-specific implants (PSI) [1,
4, 40]. Both techniques—CAM/CAD and preoperative tem-
plate molding—require a second operation. The aim of this
study was to evaluate the clinical, radiological, and cosmetic
outcomes of a time-saving and inexpensive intraoperative
method to mold custom-made implants for either immediate
single-stage or delayed cranioplasty.
Materials and methods
Study patients and procedure-related data
Data were collected from consecutive patients in whom
cranioplasty became necessary after removal of bone flaps
affected by intracranial infection, tumor invasion, or trauma
from June 2006 to June 2009 (Fig. 1). Collected data in-
cluded sex, age at time of cranioplasty, indication for cra-
niectomy (infection, tumor invasion, or trauma), diagnosis
(histology and bacterial culture), localization of craniectomy
or cranioplasty, treatment strategy (immediate or delayed
surgery), duration of the intraoperative molding procedure
and cranioplasty fixation technique (Matrix™ titanium
plates, Craniofix®, and non-absorbable sutures), and post-
operative adverse events. A wound drain was placed for at
least 1 day in all cases. Patients were monitored in the
neurosurgical intermediate care unit or the intensive care
unit for 24 h after surgery. Daily clinical observation and
routine laboratory checks for infection (leukocytes and C-
reactive protein), as well as electrolyte controls, until dis-
charge were conducted for all patients.
Molding procedure
The technique used to create template-molded PSIs has been
described previously in a technical note of two patients with
cranial defects from infection and tumor invasion, respec-
tively [13]. This molding method has become part of our
routine clinical practice. Briefly, the patient’s own bone flap
served as a template to mold a negative form with the use of
PMMA (Palacos® R 2× 40, Essex Chemie AG, Lucerne,
Switzerland). After hardening of this negative imprint, the
definitive PMMA replica was cast in between the original
bone flap and the negative form. This allowed the replica to
have exactly the same shape, thickness, and dimensions as
the bone flap and negative form (Fig. 2). A fine plastic foil
Fig. 1 Intraoperative template-molded bone flap reconstruction for
patient-specific cranioplasty can be performed after bone flap loss
due to infection, tumor invasion, or comminuted fractures. Whereas
restoration of a skull defect due to infection has to be delayed in all
cases, tumor- and trauma-associated defects may undergo immediate
reconstruction
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or a paraffin oil film was applied in between the bone flap,
the replica, and the negative form to prevent adhesion. After
sieve-like perforation, the implant was inserted and fixed
either with non-absorbable sutures (Ethibond® Excel,
Johnson & Johnson, Ethicon™, Spreitenbach, Switzerland),
the CranioFix® clamp system (B. Braun Medical Inc.,
Tuttlingen, Germany), or mini-titanium low plates and
PlusDrive® cranial screws (Low Profile Neuro Set 1.6;
Synthes, Solothurn, Switzerland).
If immediate single-stage reconstruction (e.g., for tu-
mor manifestation, trauma) was not possible (e.g., bone
flap infection, contamination), the bone flaps were re-
moved, scrubbed, soaked in antiseptic solution for at
least 30 min (Betadine, Mundipharma AG, Basel, Swit-
zerland), and sealed in sterilized biohazard red plastic
bags. The unsalvageable bone flaps were sterilized/auto-
claved before they served as an intraoperative template
(134°C, 18 min, fractionized vacuum, 1,300 mbar
[Schaerer AG, Muensingen, Switzerland]). All patients,
irrespective of prior infection or not, received a prophy-
lactic single-shot antibiotic treatment with 1.5 g/day of
cefuroxime (IV; Zinacef; Sandoz Pharmaceuticals AG,
Steinhausen, Switzerland) 1 h prior to skin incision. In
all cases, it was left to the surgeon’s discretion to
proceed with a cranioplasty procedure or to postpone
cranioplasty due to signs of infection or suspected brain
swelling later on in the course of the disease.
Clinical and radiological endpoints
Clinical and radiological evaluation was conducted during
standard follow-up at 2 months post-surgery. The cosmetic
appearance on physical examination was graded on a four-
tier scale (excellent, good, fair, and poor) based on the
surgeon’s evaluation and the patient’s subjective opinion.
Radiological assessment was obtained by computed tomog-
raphy (CT) scans with three-dimensional (3D) skull recon-
struction of the affected site. The studies included a check
for signs of infection, hydrocephalus, cerebrospinal fluid
(CSF) collections or fistulas, correct alignment of the cra-
nioplasty, and implant size and thickness.
Alignment was considered excellent when the surface
dislocation of the implant compared to the skull bone con-
tour was less than 1 mm (according to 1 mm section CT
images). Alignment was considered accurate if the implant
dislocation was at least equal to the thickness of the sur-
rounding skull, and inaccurate if greater than the thickness
of the surrounding skull. Thickness of the cranioplasty was
compared with the contralateral side in an axial CT scan.
Image sections of the greatest diameter of the bone flap in
anterior posterior dimension were selected (Fig. 3b). To
measure symmetrically, two equal distances of the midline
were identified. Then, the same dimensions of an equally
measured distance of the bone flap were divided into three
identical parts (resulting in three intersection points: #1–#3).
Fig. 2 Palacos® is prepared and molded over the bone flap (a). Excess
material is cut along the bone flap edge to obtain an accurate cast
(Negative Form, b). After hardening of the negative imprint, the
definitive replica is cast in between the bone flap and the negative
form (Implant, c). While the Palacos® compound is still in its soft state
of aggregation, accurate thickness is achieved through gentle distrib-
uted squeezing of the implant in between the negative form and the
bone flap. Again, additional Palacos® is cut away, resulting in an
implant with exactly the same shape, thickness, and dimensions of
the original bone flap (d). Paraffin oil or a fine layer of plastic
guarantees an adherence-free molding procedure. After a sieve-like
perforation, the implant is reinserted without the need for additional
adaptation procedures (e). Accurate alignment is verified in 3D CT
scans (f)
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In the midline of this third, the skull thickness was measured
using automated measurement software (8-slice General
Electric Lightspeed Ultra CT scanner, Fairfield, Connecti-
cut, USA). The intersection points (#1–#3) were then mir-
rored on the contralateral skull (#1*–#3*) and compared.
Short- and long-term follow-up was conducted after cra-
nioplasty. Patients were evaluated in the outpatient clinic
2 months after surgery and interviewed by telephone 1 to
3 years post-cranioplasty. The evaluation of the telephone
interview included the patients’ overall satisfaction with the
surgical procedure (cranioplasty as a whole) and subjective-
ly experienced cosmesis using the Odom criteria [39] and
the visual analogue scale for cosmesis (VASC) [7].
Statistical methods
Values were expressed as mean ± standard deviation (SD).
Statistically significant differences in procedure-related and
outcome data between the indication groups were deter-
mined using Student’s paired t test. A p value<0.05 was
considered significant.
Results
A total of 27 patients underwent intraoperative template-
molded patient-specific cranioplasty (age 54±19 years,
range 18–78 years). Table 1 includes an overview of patient
characteristics and surgical data.
Indications
The indications for cranioplasty were bone flap infection
(56%, n015), cranial defect from tumor infiltration (37%,
n010), and trauma (7%, n02) (Table 1). Bone flap removal
Fig. 3 Infected bone flaps are packed in sterile plastic bags, which
cause small wrinkles on the negative imprint and consequently on the
final implant (white arrows, a). Due to the accurate molding procedure,
the implant thickness does not significant differ when compared to the
contralateral mirrored skull (b). With intraoperative template-molded
patient-specific implants, exact three-dimensional skull contours can
be maintained (especially in complex pterional shapes) (white dashed
ellipse, c)
Table 1 Patient characteristics and procedure-related data
Patient characteristics
Age (mean ± SD) 54±19 years (n027)
Sex
Female 37% (n010)
Male 63% (n017)
Indication
Infection 56% (n015)
Primary 13% (n02)
Streptococcus 100% (n02)
Secondary 87% (n013)
Propionibacterium 46% (n06)
Staphylococcus 23% (n03)
Streptococcus 15% (n02)
Others 15% (n02)
Tumor 37% (n010)
Meningioma 70% (n07)
Hemangiopericytoma 20% (n02)
Osteoma 10% (n01)
Trauma 8% (n02)
Procedure
Cranioplasty molding time
(min)a (mean ± SD)
19±7 min (n027)
Infection 19±7 min (n015)
Tumor 20±6 min (n010)
Trauma (minimum; maximum) 16 min (16;16) (n02)
Size of cranioplastyb (mean ± SD) 47±23 cm2 (n027)
Infection 57±18 cm2 (n015)
Tumor 31±15 cm2 (n010)
Trauma (minimum; maximum) 51 cm2 (63;39) (n02)
Single-stage reconstruction (%) 39% (n011)
Infection 0% (n00)
Tumor 35% (n010)
Trauma 4% (n01)
Fixation technique (%)
Matrix™ 67% (n018)
Craniofix® 22% (n06)
Non-absorbable sutures 11% (n03)
a Cranioplasty molding times did not differ significantly (p00.33)
between cases of infection or tumor
b Cranial defects in patients with tumor were not significantly (p00.07)
smaller than those in patients with infection
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due to secondary bone flap infection (87%, n013) was
a more frequent procedure than removal for primary
infection without previous cranial surgery (13%, n02).
In both cases with primary infection, the germ was a
Streptococcus. In the case of secondary infection, Pro-
pionibacterium acnes was the most common germ
(46%, n06), followed by Staphylococcus (23%, n03),
and Streptococcus (n02). In the case of removal of the
bone flap due to tumor invasion, immediate cranioplasty
was performed in all instances (n010). Cranioplasty
became necessary after surgery for meningiomas in sev-
en patients (70%), for hemangiopericytoma in two
patients (20%), and for osteoma in one patient (10%).
Instable extensive multi-fragment bone flap fractures
were the reason for skull defect repair in two patients
(8%). Single-stage reconstruction was feasible in one
patient without underlying cerebral contusions and no
signs of brain swelling. In another patient with exten-
sive skull fracture who suffered significant traumatic
brain injury, the fragments were collected, reassembled,
and used as template for delayed cranioplasty.
Procedure-related data
The mean duration of molding the cranioplasty was 19±
7 min (n027, range 11–34 min). Cranioplasty molding
times did not differ significantly between cases of infection
or tumor (mean 20±7 min, n015, range 11–34 vs 20±
6 min, n010, range 15–27 min, p00.33). Implant sizes
ranged from 10 to 106 cm2 (mean size 47±23 cm2). The
cranial defects in patients with tumors were not significantly
smaller than those in patients with infection (mean 31±
15 cm2, n010, range 17–61 vs 57±18 cm2, n015, range
10–106 cm2, p00.07). The total manufacturing costs for a
single replica amounted to less than 200 United States
Dollar (USD), including 90 USD (times two) for the cost
of material for the PMMA to mold a negative form and the
definitive implant in addition to costs for various expend-
able items such as biohazard plastic bags, fine plastic foils,
and paraffin oil.
Single-stage reconstruction was possible in a substantial
number of cases (39%, n012). Immediate cranioplasty was
performed in all cases of tumor infiltration (100%, n010)
and in one case of trauma with exclusive vast comminuted
skull fracture without significant brain contusion and with
normal intracranial pressure (50%, n01 out of 2). There was
no case of immediate cranioplasty in patients (n015) with
loss of their bone flap due to infection.
In most of the cases (67%, n018), the implants were
secured using the Craniofix® titanium clamp system with
three-point fixation. Matrix™ titanium plates (22%, n06)
and non-absorbable sutures (11%, n03) were less frequently
used fixation methods.
Clinical and radiological follow-up
None of the patients showed new postoperative neurological
deficits. One patient (3.7%) developed fever and meningitis
3 days after surgery. In this case, CT scan confirmed the
clinical suspicion of an implant infection, and Klebsiella
oxytoca was isolated from the subsequently removed im-
plant. As this patient initially underwent cranioplasty (cra-
niectomy due to severe brain injury/trauma) after bone flap
infection caused by another germ (beta-hemolytic Strepto-
coccus group G), we assume that there was no relation to
our molding procedure. All remaining patients presented
with an uneventful postoperative course.
The cosmetic results at 2 months follow-up (n026) were
considered “excellent” in 21 patients (81%) and “good” in five
patients (19%) (Table 2). Radiological follow-up at 2 months
post-surgery revealed excellent implant alignment in 96% of
cases (Fig. 3a, c). Only one patient (4%) showed slight overlap
of the implant border in relation to the skull bone. In all cases,
there were no signs of infection, hydrocephalus, subcutaneous
CSF collection, or fistulas. The implant thickness at all
three intersection points (#1–#3) did not significantly
differ when compared to the thickness of the contralat-
eral mirrored skull (#1*–#3*) (#1: mean 4.9±0.3 mm,
range 2.8–8 mm vs #1*: mean 5.1±0.3 mm, range 2.7–
7.8 mm, p00.76; #2: mean 4.5±0.4 mm, range 2.6–
9 mm vs #2*: mean 4.5±0.4 mm, range 2.3–9 mm,
p00.47; #3: mean 4.6±0.4 mm, range 2.5–10 mm vs
#3*: mean 4.7±0.5 mm, range 1.8–11 mm, p00.43).
Four patients were lost to long-term follow-up. Three of
these patients died unrelated to the cranioplasty procedure and
one patient declined to participate in follow-up evaluation.
The long-term survey of the remaining patients (n023) was
performed at a mean of 17±9 months (range 7–40 months)
after cranioplasty. Overall satisfaction with the surgical pro-
cedure was considered excellent (70%, n016) or good (26%,
n06) in all but one patient. The patient with a poor overall
outcome (4%, n01) named fluctuating subcutaneous CSF
collections as the reason for dissatisfaction. Analysis of the
VASC showed that most patients were satisfied with their
esthetic outcome (mean VASC08.5±2.3, n023, range 1–
10). There were no significant differences in subjectively
experienced cosmesis in patients with cranioplasty for infec-
tion compared to patients who underwent cranioplasty due to
tumor removal (mean 8.9±1, n010, range 7–10 vs 7.9±2.5,
n011, range 1–10, p00.49). Clinical outcomes and radio-
graphic findings are summarized in Table 2.
Discussion
The results of our study demonstrate that intraoperative
template-molded PMMA cranioplasty is a fast, safe, precise,
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and inexpensive technique for reconstructing skull defects
after bone flap loss due to infection, tumor invasion, or
trauma. Cranioplasty with the presented cast-molded pros-
theses resulted in favorable cosmesis even in large defects
and anatomically complex regions. The intraoperative mold-
ing procedure provides immediate single-stage patient-
specific cranial reconstruction in a substantial number of
patients and spares these patients from potential risks of
delayed cranioplasty.
The indication for reconstructive cranioplasty is depen-
dent on the size and location of the defect, but is considered
appropriate in defects larger than 10 cm2 in order to protect
the subjacent brain against trauma [11]. Any bone defect
may eventually lead to depression of the skin and thereby
result in a malformed appearance, regardless of size [15].
Psychosocial (stigmatization of mental impairment) and
psychological (anxiety stemming from concern about pos-
sible trauma) factors may even justify cranioplasty regard-
less of the defect size [15, 20]. Along with primary
subjective symptoms, including headache, dizziness, fatiga-
bility, mental depression, intolerance to vibration, and dis-
comfort around the craniotomy site (especially during warm
weather), patients with large skull defects can also develop
objective neurological deficits. These symptoms are known
as “the syndrome of the trephined” [19, 23] and “syndrome
of the sinking skin flap”, respectively [14, 38, 45].
Although the time up to delayed cranioplasty is only a
few months, psychosocial aspects, the feeling of not being
protected against trauma, and esthetic considerations during
that time should not be underestimated [11]. Prompt cranio-
plasty spares the patient from above mentioned unpleasant
conditions, positively affects cerebral metabolism, and may
facilitate patient rehabilitation [30, 44]. Immediate cranio-
plasty is preferable in all patients and is considered techni-
cally no more difficult, if not easier and faster, than delayed
procedures [32]. In most patients where the bone flap has to
be discarded due to tumor invasion, prompt patient-specific
reconstruction using the described method is feasible. In all
other cases, it is left to the surgeon’s discretion to proceed
with the cranioplasty procedure or to postpone cranioplasty
due to signs of infection or suspected brain swelling later on
in the course of the disease. A single-stage approach to
manage skull defects avoids the risk of a second procedure,
with potential difficulties caused by soft tissue contracture
and scar bridging. Furthermore, costs of a second hospital-
ization, additional imaging procedures, and surgery can be
saved.
Reimplantation of the patient’s own bone flap may re-
main the best procedure to reconstruct cranial defects. In
order to salvage infected bone flaps, numerous methods
have been proposed, including wash-in, wash-out indwell-
ing antibiotic irrigation systems [3], aggressive surgical
debridement and delivery of systemic antibiotics [6], auto-
purifying by the patient’s immune system [46], or autocla-
vation [21] which has also been advocated in cases of tumor
invasion [43]. However, when primary bone graft reimplan-
tation becomes impossible (comminuted fractures, skull
bone infection, tumor infiltration, or storage difficulties),
cranioplasty using bone substitutes has to be considered.
Table 2 Radiological and clinical outcomes at 2 months and cosmetic
results at 1.4 years
Results 2 months post-cranioplastya
(n026)
Clinical follow-upb
Excellent 81% (n021)
Good 19% (n05)
Fair 0% (n00)
Poor 0% (n00)
Radiological follow-upa
Excellent 96% (n025)
Accurate 4% (n01)
Inaccurate 0% (n00)
Implant thicknessc
Cranioplasty flap (mean ± SD) 4.7±1.6 mm
Measurement #1 4.9±0.3 mm
Measurement #2 4.5±0.4 mm
Measurement #3 4.6±0.4
Mirrored skull (mean ± SD) 4.8±1.8 mm
Measurement #1* 5.1±0.3 mm
Measurement #2* 4.5±0.4 mm
Measurement #3* 4.7±0.5 mm
Results 1.4 years post-cranioplastyd
(n023)
Cosmetic resultsd
Patient’s VASC (mean ± SD)e 8.5±2.3 (n023, “infection,
tumor, and trauma”)
Infection (mean ± SD) 8.9±1 (n010, “infection”)
Tumor (mean ± SD) 7.9±2.5 (n011, “tumor”)
Trauma (mean) (min; max) 8.7 (7.5; 9.9) (n02, “trauma”)
Patient’s satisfaction
Excellent 70% (n016)
Good 26% (n06)
Fair 0% (n00)
Poor 4% (n01)
a One patient lost for follow-up
b Surgeon’s evaluation
c There were no significant differences (#1 vs #1*, p00.76; #2 vs #2*,
p00.47; #3 vs #3*, p00.43) in implant cranioplasty thickness when
compared to the contralateral mirrored skull
d Four patients lost for follow-up
e Visual analogue scale for cosmesis (VASC) was scored by patients on
a scale of 1–10. There were no significant (p00.49) differences in
subjectively experienced cosmesis in patients with cranioplasty for
infection compared to patients who underwent cranioplasty due to
tumor removal
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Various materials—most frequently PMMA, titanium, and
HA—have been used for surgical correction of skull defects.
It is unclear which alloplastic graft provides the best overall
results, and the choice is mainly based on personal experi-
ence and economic considerations. Because of its good
biocompatibility, low radiopacity, strong resistance to func-
tional stress, easy handling, and low costs, PMMA is the
most frequently used material and is still regarded as the
material of choice [33, 37]. Despite these advantages, one
has to be aware of exothermic reactions, toxic fumes during
mixing, and rare allergic reactions [26, 29]. Titanium is
another widely used implant material because it is fairly
radiolucent, neither magnetic nor paramagnetic, and pos-
sesses excellent biocompatibility with minimal fibrous en-
capsulation. Titanium does not cause hypersensitivity
reactions, is relatively inexpensive, and shows low graft
infection rates compared with PMMA implants, autoclaved
grafts, and autogenous grafts [36]. Potential drawbacks for
follow-up evaluations (e.g., meningioma) are the suboptimal
results of imaging quality due to titanium artifacts [7].
Although much more costly, HA is increasingly used in
craniofacial reconstruction. Despite the high biocompatibil-
ity (osteoconductivity and osteointegration), inflammatory
reactions have been described in various studies, and mate-
rial costs exceed those of titanium and PMMA [34, 35, 37].
Apart from safety and economical considerations, the pri-
mary rationale behind an immediate reconstruction is the
potential benefit to functional, esthetic, and psychological
outcomes [11, 30, 32].
The costs for CAM/CAD implants greatly exceed the
expenses for intraoperative template-molded patient-
specific implants. Large ceramic plates can cost from
5,000 to 7,000 USD, whereas titanium implants range from
2,000 to 5,000 USD. The production costs for our intra-
operative template-molded PMMA cranioplasty implants
averaged 200 USD per piece. Aside from the 10- to 20-
fold greater manufacturing/production costs, CT workload
and radiation exposure can be reduced using the presented
technique. Furthermore, in a substantial number of patients,
a second operative procedure, with hospitalization and as-
sociated costs, can be avoided with an intraoperative single-
stage approach.
Correct thickness is required with PMMA cement to
create a graft that is uniformly strong, without thin regions
and thus without potential fracture sites. Correct positioning
and size of the implant not only results in cosmetically
favorable outcomes, but also reduces operation time for
adjustment and insertion, minimizes bone flap subsidence,
wound dehiscence due to tensionless wound closure, wound
infection, and finally revision operations [18]. Furthermore,
thermal tissue damage caused by an exothermic polymeri-
zation reaction during hardening [17] and cytotoxic damage
using PMMA implants by direct molding on the lesion [24]
have been reported. With the presented procedure, due to the
fact that molding is indirect and removed from the involved
sensitive tissue, no damage occurs using PMMA. Patient-
specific reconstruction for small cranial vault defects, as
often seen after surgery for bone invasive tumors or de-
pressed skull fractures, remains controversial. Even though
additional costs (100 USD for the negative form) using the
described intraoperative template-molded technique are low,
operation time is extended by approximately 20 min. In
small defects, good cosmetic outcomes and bony alignment
can also be achieved by free-hand molding cranioplasty
using PMMA or titanium mesh [32].
Infection was the leading indication for alloplastic cra-
nioplasty in this series. The most common germ in our series
was P. acnes. This anaerobic Gram-positive bacillus, found
as a normal component of the bacterial flora of the skin, is a
common causative germ for infection after craniotomy [25].
The most common infecting organism is reported to be
Staphylococcus aureus [10], which was the second most
common bacterium in our series. The incidence of bone flap
infection following routine cranioplasty is about 6–12% [9,
36, 37]. Cranioplasty in patients with a history of previous
infection has approximately 10–15% higher risk of infection
[31]. In a 4-year, retrospective cranioplasty study with 131
patients using PMMA prostheses, clinical follow-up for a
minimum of 6 months revealed that the infection rate asso-
ciated with prefabricated PMMA prostheses was lower
(5.8%) than that for intraoperatively molded PMMA pros-
theses (13%) [28]. The infection rate in the study patient
population remains to be determined in clinical long-term
follow-up. The infection rate of the present series of intra-
operatively template-molded PMMA implants (3.7%) with a
clinical follow-up of at least 7 months is comparable to the
reported infection rate (5.8%) using prefabricated PMMA
prostheses [28]. However, long-term infection rate in this
study patient population remains to be determined.
Despite all the listed advantages of the presented tech-
nique, there is an important limitation. As already noted by
Gliese et al. who described a similar method for alloplastic
flap modeling, the patient’s own bone flap is an irreplace-
able element of the described technique [16]. In their elegant
technique, a negative imprint of the patient`s original bone
flap is performed prior to surgery. This cast is then auto-
claved and serves as a template at the time of cranioplasty.
In our series, all infected bone flaps had to be autoclaved
and packed into sterile bags. For extensive comminuted
fractures, it was vital to bring together all pieces to achieve
a proper template for the molding procedure. In the case of
bone resorption or extensive tumor destruction, an adequate
template is not available and free-hand techniques or CAM/
CAD becomes the alternative cranioplasty method. Another
option, when the prerequisite of the own bone flap is miss-
ing, is to perform split calvarium cranioplasty. Fresh
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autologous bone has the highest possible biocompatibility,
fuses with the adjacent bone, and often completely revital-
izes. Although none of the patients of the present series were
younger than 19 years of age, the split calvarial bone graft
technique should be considered for reconstruction of pedi-
atric skull defects [22].
Conclusion
Intraoperative template-molded cranioplasty using PMMA
provides a feasible, fast, and cost-efficient method to pre-
cisely reconstruct the patient’s own bone flap in terms of
alignment and thickness. This molding method is safe,
results in excellent cosmetic outcomes, and can be applied
in early and delayed cranioplasty procedures. Single-stage
reconstruction spares a substantial number of patients from
unpleasant conditions with potential benefits for functional,
esthetic, and psychological outcomes.
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Comments
Siamak Asgari, Ingolstadt, Germany
The authors presented a retrospective study about 27 patients, who
underwent one- or two-stage surgery for cranioplasty. Indication for
cranioplasty were posttraumatic skull defects (n02), resection of
tumors with skull involvement (n010), and bone flap infection (n0
15). The authors described a method of template-molded PMMA
cranioplasty. The authors gave a very detailed analysis of intraopera-
tive characteristics and the postoperative cosmetic results. Altogether,
the described cranioplasty procedure is very cost-effective and showed
excellent radiological and esthetic results. Finally, the main limitation
of this strategy, the autologous bone resorption, was mentioned.
Philippe Bijlenga, Geneva, Switzerland
With more and more decompressive craniectomies performed for
different reasons, a simple, safe, quick, and low-cost solution for
cranioplasty, as described in this article, is very welcome.
The authors describe a simple method to generate a negative print
of the patient’s bone flap that can then be used as a cast to build a
Palacos® cement replica. This article shows that the method is not only
feasible but also safe and rapid and presented an excellent radiological
and cosmetic outcome in 27 patients. The method that is described in
this article presents a long list of advantages and a unique limitation
that resides in the absolute need of the original patient’s bone flap to
serve as a model. Readers are invited to make their own experience and
the future will tell us if the technique holds its promises and becomes a
worldwide standard.
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